Navigation Links
Nonin Medical Announces Continua™ Certified USB Data Transfer Device for Its Handheld Oximeter Line
Date:9/17/2010

MINNEAPOLIS, Sept. 17 /PRNewswire/ -- Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, today has introduced its latest Continua™ Certified device, the 1000USB-C USB adapter. Designed for OEM system developers, the 1000USB-C adapter enables any of Nonin's handheld oximeters to conveniently transfer secure data in accordance with Continua Health Alliance guidelines.

The second in a line of USB adapters released by Nonin this year, the 1000USB-C adapter contains three interface ports for simple connection between any Nonin handheld oximeter, patient sensor and receiving device. With this advance, Continua-compliant pulse oximetry (SpO2) data can now be securely transmitted in real time to various service providers such as health care facilities, disease management services or personal health record (PHR)/home telemedicine services.

Nonin's physiological monitoring products for telemedicine are the prevailing gold standard for vital sign assessment in a wide range of chronic diseases such as chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF) and asthma. This announcement is further evidence of Nonin's leadership position in telemedicine and commitment to the advance of innovative, interoperable solutions designed to contain costs in the health care market.

Since certifying the world's first Continua™ Certified product in January of 2009, Nonin continues to add interoperable solutions across its entire product line and is a proud recipient of Frost and Sullivan's 2009 North American Product Line Strategy Award in Remote Patient Monitoring. Earlier this year, Nonin showcased its Onyx® II, Model 9560, the world's first Continua Certified Bluetooth® fingertip pulse oximeter, as part of the first end-to-end Continua-connected health solution with partners IBM and Vignet. For more information on the Continua Health Alliance visit, www.continuaalliance.org.

About Nonin Medical Inc. - www.nonin.com

Minneapolis-based Nonin Medical, Inc. is a privately owned company specializing in the design and manufacturing of noninvasive physiological monitoring solutions. Nonin distributes its products to health professionals in more than 125 countries and has over 100 OEM partners worldwide. With over 20 years of industry-leading capabilities in signal processing and sensor design expertise, Nonin's innovative noninvasive physiological technologies enable clinicians to accurately monitor a patient's true condition in the most challenging environments.


'/>"/>
SOURCE Nonin Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Masimo Noninvasive and Continuous Hemoglobin Receives Market Clearance in Japan
2. Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System
3. Nonin Medical Introduces Latest Generation of Veterinary Handheld Pulse Oximeter for Global Distribution
4. Nonin Medical Announces Expanded Distribution Partnership With CareFusion
5. Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership
6. Noninvasive Breath Test Predicts Survival in Patients with Viral Hepatitis
7. Nonin Medical Recognized for Influential Contributions in Medical Technology
8. New Clinical Studies Demonstrate the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring Technology
9. Noninvasive Medical Technologies Awarded ISO 13485 Quality Certification
10. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
11. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):